Scientists in the United States have achieved a major milestone in regenerative medicine by advancing 3D-printed liver tissue that could help address the global shortage of donor organs and transform transplant medicine. Researchers at Carnegie Mellon University received a $28.5 million award from the U.S. Advanced Research Projects Agency for Health (ARPA-H) to develop a bioprinted liver patch designed to support patients with acute liver failure and potentially reduce the need for full liver transplants.
How the Technology Works
Using a technique called FRESH (Freeform Reversible Embedding of Suspended Hydrogels), scientists are printing complex vascularized human liver tissue composed entirely of human cells and structural proteins. This engineered tissue is designed to be immune-compatible, meaning it could function without the need for intense immune-suppressing drugs that are standard in traditional organ transplants.
The approach focuses first on creating liver patches to help patients through critical periods of acute liver failure — providing time for their own organs to recover — but researchers hope the method could eventually extend to larger, fully functional organs.
Potential Beyond the Liver
While the immediate goal is to tackle liver failure, the broader implications of this work could extend to other vital organs such as the pancreas, heart, and kidneys. Experts say that bioprinted tissues could serve as an alternative or bridge to conventional transplants, alleviating the chronic shortage of donor organs that leaves thousands waiting and many dying each year.
This research builds on a larger trend in biofabrication, where engineered tissues and organs are increasingly moving from experimental labs toward clinical viability.
Small Lifestyle Changes Show Big Health Benefits
In related health news, a new international study found that adding just five minutes of brisk physical activity per day and reducing sedentary time by 30 minutes could significantly improve longevity and reduce premature deaths globally — especially among the least active populations. The research highlights the power of simple, achievable daily habits in boosting long-term health outcomes.
Global Watch on Illness and Disease Risk
Public health agencies are also tracking the simultaneous circulation of influenza and respiratory syncytial virus (RSV) during the 2025–26 season, warning that overlapping outbreaks could strain healthcare systems if preparedness is not strengthened in coming weeks.
At the same time, communicable disease surveillance reports across Europe indicate ongoing activity for measles, mpox, and other respiratory viruses, underscoring the need for robust monitoring and vaccination campaigns.
Challenges in Health Investment and Costs
Looking at broader systemic issues, a new World Economic Forum report warns that women’s health receives only about 6 % of private healthcare investment worldwide, despite women accounting for nearly half the global population. The analysis calls for stronger evidence and increased funding to tackle underfunded conditions such as cardiovascular disease, menopause and Alzheimer’s.
Meanwhile, insurers predict that global healthcare costs will rise by more than 10 % in 2026, driven by rising medical and outpatient expenses, placing further pressure on health systems and employers.
What This Means for 2026
Together, these developments — from cutting-edge organ bioprinting and simple lifestyle interventions to disease surveillance and funding gaps — highlight how science, policy, and behaviour intersect in global health. As new technologies emerge, and as public health systems adapt to overlapping disease threats and rising costs, experts say 2026 will be a test of both innovation and resilience in health worldwide.
